Пятый элемент здоровья. Как использовать менструальный цикл для поддержания жизненно важных функций организма

2. Tschudin, Sibil, Paola Coda Bertea, and Elisabeth Zemp. “Prevalence and predictors of premenstrual syndrome and premenstrual dysphoric disorder in a population-based sample.” Archives of Women’s Mental Health 13, no. 6 (2010): 485–494; Dueñas, José Luis, Iñaki Lete, Rafael Bermejo, Agnès Arbat, Ezequiel Pérez-Campos, Javier Martínez-Salmeán, Isabel Serrano, José Luis Doval, and Carme Coll. “Prevalence of premenstrual syndrome and premenstrual dysphoric disorder in a representative cohort of Spanish women of fertile age.” European Journal of Obstetrics & Gynecology and Reproductive Biology 156, no. 1 (2011): 72–77; Takeda, T., K. Tasaka, M. Sakata, and Y. Murata. “Prevalence of premenstrual syndrome and premenstrual dysphoric disorder in Japanese women.” Archives of Women’s Mental Health 9, no. 4 (2006): 209–212; ACOG committee opinion. Premenstrual syndrome. Number 155–April 1995 (replaces no. 66, January 1999). Committee on Gynecologic Practice. American College of Obstetricians and Gynecologists. International Journal of Gynecology & Obstetrics 50 (1995): 80–84.

3. Prior, Jerilynn C., Chiaki Konishi, Christine L. Hitchcock, Elaine Kingwell, Patti Janssen, Anthony P. Cheung, Nichole Fairbrother, and Azita Goshtasebi. “Does molimina indicate ovulation? Prospective data in a hormonally documented single-cycle in spontaneously menstruating women.” International Journal of Environmental Research and Public Health 15, no. 5 (2018): 1016.

4. Magyar, David M., Stephen P. Boyers, John R. Marshall, and Guy E. Abraham. “Regular menstrual cycles and premenstrual molimina as indicators of ovulation.” Obstetrics & Gynecology 53, no. 4 (1979): 411–414; Harvey, Anne T., Christine L. Hitchcock, and Jerilynn C. Prior. “Ovulation disturbances and mood across the menstrual cycles of healthy women.” Journal of Psychosomatic Obstetrics & Gynecology 30, no. 4 (2009): 207–214.

5. Owen, Lara. (2008). Her Blood Is Gold: Awakening to the Wisdom of Menstruation. Wimborne, UK: Archive Publishing, 60.

6. Scommegna, Antonio, and W. Paul Dmowski. “Dysfunctional uterine bleeding.” Clinical Obstetrics and Gynecology 16, no. 3 (1973): 221–254.

7. Lovick, Thelma A., Vinicius G. Guapo, Janete A. Anselmo-Franci, Camila M. Loureiro, Maria Clara M. Faleiros, Cristina M. Del Ben, and Marcus L. Brandão. “A specific profile of luteal phase progesterone is associated with the development of premenstrual symptoms.” Psychoneuroendocrinology 75 (2017): 83–90; Munday, M.R., M.G. Brush, and R.W. Taylor. “Correlations between progesterone, oestradiol and aldosterone levels in the premenstrual syndrome.” Clinical Endocrinology 14, no. 1 (1981): 1–9; Wide, Leif, Ragnar So, and Hans Carstensen. “FSH, LH, TeBG-capacity, estrogen and progesterone in women with premenstrual tension during the luteal phase.” Journal of Steroid Biochemistry 7, no. 6–7 (1976): 473–476.

8. Stewart, W.F., C. Wood, M.L. Reed, J. Roy, and R.B. Lipton. “Cumulative lifetime migraine incidence in women and men.” Cephalalgia 28, no. 11 (2008): 1170–1178; Pizzorno, Joseph E., and Michael T. Murray. (2013). Textbook of Natural Medicine, 4th edition. St. Louis, MO: Elsevier/Churchill Livingstone, 1468.

9. Pavlović, Jelena M., Walter F. Stewart, Christa A. Bruce, Jennifer A. Gorman, Haiyan Sun, Dawn C. Buse, and Richard B. Lipton. “Burden of migraine related to menses: results from the AMPP study.” The Journal of Headache and Pain 1, no. 16 (2015): 1–11; Granella, Franco, Grazia Sances, Carla Zanferrari, Alfredo Costa, Emilia Martignoni, and Gian Camillo Manzoni. “Migraine without aura and reproductive life events: a clinical epidemiological study in 1300 women.” Headache: The Journal of Head and Face Pain 33, no. 7 (1993): 385–389; Warnock, Julia K., Lawrence J. Cohen, Harvey Blumenthal, and Jordan E. Hammond. “Hormone-related migraine headaches and mood disorders: treatment with estrogen stabilization.” Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy (2016): 120–128; Sacco, Simona, Silvia Ricci, Diana Degan, and Antonio Carolei. “Migraine in women: the role of hormones and their impact on vascular diseases.” The Journal of Headache and Pain 13, no. 3 (2012): 177–189; MacGregor, E.A., A. Frith, J. Ellis, L. Aspinall, and A. Hackshaw. “Incidence of migraine relative to menstrual cycle phases of rising and falling estrogen.” Neurology 67, no. 12 (2006): 2154–2158.

10. MacGregor, E. Anne, and Allan Hackshaw. “Prevalence of migraine on each day of the natural menstrual cycle.” Neurology 63, no. 2 (2004): 351–353; Warnock, Julia K., Lawrence J. Cohen, Harvey Blumenthal, and Jordan E. Hammond. “Hormone-related migraine headaches and mood disorders: treatment with estrogen stabilization.” Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy (2016): 120–128.

11. Abraham, G.E. “Nutritional factors in the etiology of the premenstrual tension syndromes.” The Journal of Reproductive Medicine 28, no. 7 (1983): 446–464.